EZH2 and cancer: Apart from its role as a chromatin modulator or direct activator of oncogenic pathways, EZH2 can alter signaling pathways in cancer cells by posttranslational mechanisms that alter the properties of key signaling molecules, further supporting the complexity of EZH2 involvement in cancer biology.